Ticker
ALGSCompany Name
ALIGOS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -75.12M | -2366.82% | $ 3.17M |
3/31/2025 | $ -79.01M | -2416.21% | $ 3.27M |
12/31/2024 | $ -80.87M | -2050.01% | $ 3.94M |
9/30/2024 | $ -85.11M | -1419.16% | $ 6M |
6/30/2024 | $ -85.33M | -1071.11% | $ 7.97M |
3/31/2024 | $ -79.44M | -575.96% | $ 13.79M |
12/31/2023 | $ -79.02M | -508.83% | $ 15.53M |
9/30/2023 | $ -73.22M | -446.9% | $ 16.39M |
6/30/2023 | $ -70.01M | -405.81% | $ 17.25M |
3/31/2023 | $ -81.78M | -581.67% | $ 14.06M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Revenues
(=) FCF %
FCF % for ALIGOS THERAPEUTICS INC is calculated as follows: FCF [ $ -76.33M ] / Revenues [ $ 0 ]
(=) FCF % [ 0% ]
Minimum
Jun 30, 2021
Maximum
Jun 30, 2023
Average
Median
filtered constituents | 3.18K |
---|---|
min | -58.23% |
max | 68.19% |
average | 7.87% |
median | 7.4% |
std | 19.48% |